Women at risk of ‘preventable' cancer due to ‘alarmingly' low uptake of ‘life-saving' jab, health chiefs warn
Click to share on X/Twitter (Opens in new window)
Click to share on Facebook (Opens in new window)
YOUNG women are at higher risk of a "preventable" cancer due to "alarmingly" low uptake of life-saving NHS jabs, health chiefs have warned.
Human papillomavirus (HPV) vaccines are dished out to 12 and 13-year-olds and offer protection against cancer-causing strains of the virus.
Sign up for Scottish Sun
newsletter
Sign up
2
Low uptake oh HPV vaccines in certain parts of the country leaves young women vulnerable to cancer
Credit: AP
But low uptake of jabs in certain parts of England is leaving young women vulnerable to cervical cancer and other forms of the disease caused by HPV.
HPV is a common virus that's spread through skin contact, usually during sex.
Most strains are harmless but some high-risk ones can increase people's chances of developing cervical cancer, as well as mouth, anal, penile, vulval and vaginal cancer.
Around 13 high-risk types of HPV are known to cause 99.7 per cent of cervical cancers.
Health bosses have made it their mission to eliminate cervical cancer in England by 2040.
But despite efforts to increase vaccine uptake in teens, the latest data published by the UK Health Security Agency (HPV) shows gaps in coverage in certain parts of the country, leaving young women in these areas at higher risk of HPV-related cancer.
The data on HPV coverage in teens for 2023/24 showed that only 64.9 per cent of Year 10 female students in London had received their jabs.
Coverage was also low for boys of the same age in the capital, with only 59 per cent taking up the offer for an HPV vaccine.
Meanwhile, HPV coverage was highest in the South East for both genders - where 82.7 per cent of girls and 77.3 per cent of boys had gotten vaccinated by Year 10.
At local authority level, Year 10 vaccination levels in girls ranged from 38.7 per cent in Lambeth, South London, to 97.6 per cent in Northumberland.
Cervical cancer could be eradicated as HPV vaccine slashes 90% of cases
For boys, it ranged from 28.2 per cent in Lambeth to 92.2 per cent in West Berkshire.
Cervical cancer rates are already 65 per cent higher in England's most deprived areas compared with the least, according to figures from Cancer Research UK.
Dr Sharif Ismail, consultant epidemiologist at UKHSA, said: "The HPV vaccine, now just a single dose offered in schools, is one of the most powerful tools we have for cancer prevention.
"Every vaccination represents a young person with better protection against the devastating impact of HPV-related cancers and we must do more to ensure that no teenage girl or boy, young woman or man is denied that protection no matter where they live.
"Although we have seen some increase in the number of young people being vaccinated, uptake is still well below pre-Covid pandemic levels
"Over a quarter of young people - many thousands - are missing out on this potentially life-saving vaccine."
The HPV jab is given to boys and girls when they are in Year 8, though some children receive it in Year 9.
It delivers a significantly stronger immune response if given before the age of 16, though getting it when older as part of a catch-up programme still creates a strong response.
2
Anyone who missed their HPV vaccination, now just a single jab, can still receive it for free until their 25th birthday through their GP surgery.
Up until recently, the HPV jab was only offered to girls.
But boys also have an important role to play in helping eliminate cervical cancer by being vaccinated and not passing on the HPV virus when they become sexually active, UKHSA said.
Jabs were rolled out to teenage boys in 2019.
'Beat cancer for everyone'
Dr Ismail said: "We're calling on all parents to return their children's HPV vaccination consent forms promptly.
"This simple action could protect your child from developing cancer in the future."
Dr Ismail said any young adult up to age 25 who missed their school jab can speak to their GP about catch-up options.
He also urged women to still attend cervical screening to ensure they are being checked for changes that could lead to cervical cancer.
"Even if you've had the HPV vaccine, it's vital you still attend your cervical screening appointments when invited," Dr Ismail said.
"Both vaccination and screening together give you your best chance of protection against cervical cancer.
"Screening can detect abnormal cells before they develop into cancer, allowing for early treatment and prevention."
It comes after UKHSA warned earlier this year that over a quarter of schoolkids hadn't had their HPV jab.
Cancer Research UK chief executive Michelle Mitchell said: "Thanks to the power of research and the efforts of NHS staff, a future where almost nobody gets cervical cancer is in sight.
"This progress hinges on people's access to two life-saving offers - HPV vaccination and screening. Together, they give the best protection against the disease.
"Beating cervical cancer means beating it for everyone, so I encourage all parents and guardians to ensure young people don't miss out on getting the HPV vaccine.
"And if you receive your cervical screening invite, don't ignore it."
Dr Amanda Doyle OBE, national director for primary care and community services at NHS England, said: "The NHS HPV vaccination programme has already helped save thousands of lives and we need to go further to boost uptake of HPV vaccines and cervical screening to help eliminate cervical cancer in England by 2040.
"If we can ensure that almost every Year 10 girl in some areas is protected and extremely unlikely to ever develop cervical cancer, we need to match this in every part of the country.
"It's vital for boys and young men to be vaccinated too. Rates in boys still lag behind girls and HPV causes thousands of cancers in men as well as things like genital warts."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Powys County Times
2 hours ago
- Powys County Times
Chris Hoy calls for systemic change in testing for prostate cancer
Six-time Olympic champion Sir Chris Hoy has called for systemic change in the ways men get tested for prostate cancer. The 49-year old cyclist was diagnosed with stage four prostate cancer in 2023 and was told last year that it has spread to his bones and is terminal. NHS guidance says men over the age of 50 are at highest risk of developing prostate cancer, but Sir Chris wants to help men get screened earlier. He said: 'I was diagnosed with stage four prostate cancer at 47. By this age, my prostate cancer was advanced and could have been progressing from when I was 45 or even younger. 'With prostate cancer, the earlier you find it, the easier it is to treat. We need the system to change to enable more men to get diagnosed earlier, and stop them getting the news I got.' One option is a PSA blood test which checks the level of prostate-specific antigens in the blood, A high reading may be a sign of a prostate condition. NHS guidance says these tests are not routinely used as they are not reliable, but men over 50 can ask GPs for one. Sir Chris's comments came after Prostate Cancer UK urged the UK Government for an overhaul of NHS guidelines to encourage GPs to proactively speak to men at high risk from 45 years old. #ProstateCancer has become the most common cancer in England. However, for a disease that affects 1 in 8 men, there's still no screening programme and outdated NHS guidelines prevent lifesaving conversations with men at highest risk. ➡️ Read more: — Prostate Cancer UK (@ProstateUK) January 28, 2025 According to the charity, around one in eight men in the UK will get prostate cancer, which occurs when cells in the prostate start to grow in an uncontrolled way and, if not detected early, risks spreading. Sir Chris added: 'I believe men at highest risk, for example men with a family history like me or black men, should be contacted by their GP earlier on to discuss a simple PSA blood test that can check for signs of prostate cancer. Then if there are any issues, they can get it treated it at an earlier stage. 'I've told my story to help raise awareness about the most common cancer in men and get more thinking about their risk and what they can do, but it shouldn't all be men's responsibility. 'I've faced many challenges in my life, and going public with my prostate cancer diagnosis was certainly one of them. 'I've been incredibly lucky to have so much support from my family, friends and the general public. The kindness has lifted me up and given me a sense of purpose, and I'm committed to taking that forward and using my platform to raise awareness of the most common cancer in men and help more men at risk to come forward and get tested.' The Scottish cyclist has launched his own charity cycling challenge, Tour de 4, with the aim of changing perceptions around stage four cancer. The challenge will take place on September 7 in Glasgow with a final registration phase open for riders to sign up. Speaking about Sir Chris, Laura Kerby, chief executive at Prostate Cancer UK, said: 'His bravery and tireless work to raise awareness has already made a huge impact. 'In just a few months after Sir Chris went public with his diagnosis last year, over 286,000 people used our online risk checker to learn more about the disease, find out their own risk and learn what they can choose to do about it. 'His bravery has inspired so many men to take action, and he has undoubtedly saved lives. 'One in eight men will get prostate cancer. The earlier it's found, the easier it is to treat — but there's currently no screening programme in the UK. So if, like Sir Chris, you have a family history of the disease, or if you're black, we strongly encourage you to speak to your GP about testing from the age of 45. 'We don't think it's right that the responsibility is all on men's shoulders, so we're calling on the Health Secretary to overhaul outdated NHS guidelines so that GPs are empowered to actually start conversations with these men at highest risk.' A Government spokesperson said: 'This Government has been clear we would like to see screening in place but the decision must be evidence-led, which is why the UK National Screening Committee is looking at this as a priority – including reviewing the evidence for screening men with a family history of prostate cancer. 'While the review is taking place we are getting on with improving cancer treatment and prevention, as well as funding tens of millions of pounds of research.'
Rhyl Journal
2 hours ago
- Rhyl Journal
Chris Hoy calls for systemic change in testing for prostate cancer
The 49-year old cyclist was diagnosed with stage four prostate cancer in 2023 and was told last year that it has spread to his bones and is terminal. NHS guidance says men over the age of 50 are at highest risk of developing prostate cancer, but Sir Chris wants to help men get screened earlier. He said: 'I was diagnosed with stage four prostate cancer at 47. By this age, my prostate cancer was advanced and could have been progressing from when I was 45 or even younger. 'With prostate cancer, the earlier you find it, the easier it is to treat. We need the system to change to enable more men to get diagnosed earlier, and stop them getting the news I got.' One option is a PSA blood test which checks the level of prostate-specific antigens in the blood, A high reading may be a sign of a prostate condition. NHS guidance says these tests are not routinely used as they are not reliable, but men over 50 can ask GPs for one. Sir Chris's comments came after Prostate Cancer UK urged the UK Government for an overhaul of NHS guidelines to encourage GPs to proactively speak to men at high risk from 45 years old. #ProstateCancer has become the most common cancer in England. However, for a disease that affects 1 in 8 men, there's still no screening programme and outdated NHS guidelines prevent lifesaving conversations with men at highest risk. ➡️ Read more: — Prostate Cancer UK (@ProstateUK) January 28, 2025 According to the charity, around one in eight men in the UK will get prostate cancer, which occurs when cells in the prostate start to grow in an uncontrolled way and, if not detected early, risks spreading. Sir Chris added: 'I believe men at highest risk, for example men with a family history like me or black men, should be contacted by their GP earlier on to discuss a simple PSA blood test that can check for signs of prostate cancer. Then if there are any issues, they can get it treated it at an earlier stage. 'I've told my story to help raise awareness about the most common cancer in men and get more thinking about their risk and what they can do, but it shouldn't all be men's responsibility. 'I've faced many challenges in my life, and going public with my prostate cancer diagnosis was certainly one of them. 'I've been incredibly lucky to have so much support from my family, friends and the general public. The kindness has lifted me up and given me a sense of purpose, and I'm committed to taking that forward and using my platform to raise awareness of the most common cancer in men and help more men at risk to come forward and get tested.' The Scottish cyclist has launched his own charity cycling challenge, Tour de 4, with the aim of changing perceptions around stage four cancer. The challenge will take place on September 7 in Glasgow with a final registration phase open for riders to sign up. Speaking about Sir Chris, Laura Kerby, chief executive at Prostate Cancer UK, said: 'His bravery and tireless work to raise awareness has already made a huge impact. 'In just a few months after Sir Chris went public with his diagnosis last year, over 286,000 people used our online risk checker to learn more about the disease, find out their own risk and learn what they can choose to do about it. 'His bravery has inspired so many men to take action, and he has undoubtedly saved lives. 'One in eight men will get prostate cancer. The earlier it's found, the easier it is to treat — but there's currently no screening programme in the UK. So if, like Sir Chris, you have a family history of the disease, or if you're black, we strongly encourage you to speak to your GP about testing from the age of 45. 'We don't think it's right that the responsibility is all on men's shoulders, so we're calling on the Health Secretary to overhaul outdated NHS guidelines so that GPs are empowered to actually start conversations with these men at highest risk.' A Government spokesperson said: 'This Government has been clear we would like to see screening in place but the decision must be evidence-led, which is why the UK National Screening Committee is looking at this as a priority – including reviewing the evidence for screening men with a family history of prostate cancer. 'While the review is taking place we are getting on with improving cancer treatment and prevention, as well as funding tens of millions of pounds of research.'
Rhyl Journal
2 hours ago
- Rhyl Journal
ADHD waiting list led to rise in unregulated private providers
The ADHD taskforce, commissioned by NHS England with the support of the Government, has published an interim report saying the system for diagnosing and managing ADHD needs to be overhauled. At the moment, ADHD assessment and treatment in England is provided by highly specialised doctors in secondary care. But the report warned: 'Inability to access NHS services has led to a significant growth in the use of private providers that are not regulated, resulting in two-tier access to services, diagnosis and treatment; one for those who can pay and another for those who cannot. 'This drives health inequalities and links to disproportionate impacts and outcomes in the education and justice systems, employment and health.' Experts behind the study said waiting times for NHS ADHD services 'have escalated and are unacceptably long' and demand on services is 'very likely' to continue to rise. The taskforce concluded that ADHD is not solely the remit of the NHS and other health providers, with schools being vital for identifying and meeting needs at an early stage. And while a clinical diagnosis of ADHD via the NHS is required if a person needs medication, early support can still be provided to others. The report said: 'We need timely recognition and early support of suspected ADHD and neurodivergence across all settings. 'This is especially important in schools and the early years, to prevent adverse impacts and costly outcomes in the future. This should be needs-led and not require a clinical diagnosis.' The report also suggested there is no evidence of over-diagnosis of ADHD in the UK. It argued: 'England and the rest of the UK have much lower service recognition and treatment rates of ADHD diagnosis compared with other European countries. 'Recent data show a very high level of under-recognition and under-treatment of strictly diagnosed ADHD, with significant inequalities in access to care.' The report also addressed concerns about potential 'over-medicalisation and over-diagnosis', including worries that people are self-diagnosing ADHD based on information from social media. However, the report, said that 'currently there is no good evidence on what percentage of those waiting to see a clinician have self-diagnosed ADHD using social media and eventually meet or do not meet ADHD diagnostic criteria after a high-quality assessment. 'We only know currently that in England, recognised rates of ADHD are lower than the expected prevalence of ADHD.' Currently, the estimated economic costs of not treating ADHD are around £17 billion to the UK economy, the report went on. This includes through lower tax contributions, people needing state benefits and more likely to be not in education, employment or training, or who are long-term unemployed. 'Many of these costs are avoidable, as with appropriate, early support, people with ADHD can thrive,' it said. Professor Anita Thapar, chair of the ADHD Taskforce, said: 'The recommendations put forward by the taskforce will require action across Government and cross-sector organisations to make the necessary changes to improve the lives of people with ADHD. 'We need to get this right, to make sure people get early diagnosis and support, not just in the NHS but across society.' Dr Adrian James, NHS England's medical director for mental health and neurodiversity, said: 'We know that too many people with ADHD have been waiting for too long for support, which is why we launched the taskforce last year to help respond to the significant growth in the need for care. 'It is clear that much more needs to be done to improve ADHD assessment and care in England and ensure people can get a timely diagnosis, and we welcome the findings from the interim report, and look forward to its final conclusions later this year.' A Department of Health and Social Care spokesperson said: 'Lord Darzi's report into the state of the NHS laid out how severe the delays have become for people waiting for an attention deficit hyperactivity disorder diagnosis. 'We welcome the publication of the ADHD Taskforce's interim report, which provides valuable insights into the challenges affecting those with ADHD, including access to services and support.' The NHS has launched publicly-available data collection on ADHD referrals and waiting times to help local teams better understand how they are performing. By March 2026, the Government also aims for six in 10 pupils to have access to a mental health support team in school.
